Inpatient Smokers and LDCT Screening Part 2

NACompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

February 12, 2019

Primary Completion Date

January 28, 2020

Study Completion Date

June 4, 2020

Conditions
Lung Cancer ScreeningSmoking Cessation
Interventions
BEHAVIORAL

Smoking Cessation Counseling

All participants will receive inpatient smoking cessation counseling by the tobacco-trained NP. Inpatient smoking cessation counseling is the standard of care at BMC.

BEHAVIORAL

Decision Aid

"The AHRQ Is Lung Cancer Screening Right for me? patient decision aid is a 4-page paper format with the following features: 1) LDCT screening harms and benefits information, written in plain language and using pictographs, easily understood by those with low health literacy; 2) prompts to clarify patient values and preferences and to stimulate discussion about tradeoffs; 3) clear quit smoking messaging and resources (1-800-QUIT-NOW)"

BEHAVIORAL

Shared decision making (SDM)

"During the smoking cessation consultation, the nurse practitioner (NP) will conduct SDM, using the 4-page AHRQ Is Lung Cancer Screening Right for me? decision aid as a guide. The purpose of SDM is three-fold: 1) conduct a tailored discussion on tradeoffs of LDCT screening, consistent with Centers for Medicare \& Medicaid Services (CMS) requirements for SDM using a decision aid; 2) directly connect interested patients to LDCT screening; 3) to empower and motivate patients to quit smoking within the LDCT screening context."

BEHAVIORAL

CHW Navigation

The CHW will meet with the participant after the SDM to initiate the coordination of outpatient tobacco treatment, referral to LCS, and resources to address the barriers to preventive services. The CHW will follow patients subjects in the intervention arm for 3 months to help navigate and address negative social determinants of health that are barriers to LCS and tobacco treatment. For patients who agree to screening, the CHW will schedule the appointment, arrange the transportation to appointment, and meet participant at the appointment to facilitate the screening.

Trial Locations (1)

02118

Boston Medical Center, Boston

All Listed Sponsors
collaborator

American Lung Association

OTHER

lead

Boston University

OTHER

NCT03793894 - Inpatient Smokers and LDCT Screening Part 2 | Biotech Hunter | Biotech Hunter